Cell-based anti-ageing treatments claim to reverse skin ageing, improve vitality, or extend lifespan. Evidence for systemic anti-ageing is weak; evidence for skin improvement is modest. Most claims overshoot the science considerably.
The anti-ageing market is vast and profitable, attracting entrepreneurial clinics to offer stem cell treatments for cosmetic ageing, systemic rejuvenation, or longevity enhancement. Marketing language is alluring: "regenerate your cells," "restore youthful function," "reverse biological age." The biological rationale is plausible: senescent (aged) cells accumulate and damage tissue; stem cells produce growth factors and anti-inflammatory molecules; theoretically, stem cell infusion could counteract ageing. In practice, evidence is speculative and claims routinely overreach the data.
For skin ageing specifically, some evidence exists. Topical or dermal injection of conditioned media (liquid by which stem cells have been cultured, containing their secreted factors) shows modest improvement in skin texture, hydration, and fine lines in small studies. Autologous fat-derived stem cells, injected subdermally, can improve skin quality and provide some filler effect. However, these benefits are small compared to established cosmetic interventions like chemical peels, laser resurfacing, or surgical facelifts. A patient expecting dramatic facial rejuvenation from stem cell therapy will be disappointed. Cost-benefit is poor; you're paying €10,000–€25,000 for results comparable to a €3,000–€5,000 professional facelift.
For systemic anti-ageing—intravenous stem cell infusions claiming to improve energy, organ function, or lifespan—evidence is almost nonexistent. A few small uncontrolled studies report subjective improvements in fatigue or cognition after MSC infusion, but without proper controls, baseline changes in fitness or sleep, placebo effects (which are potent in subjective outcomes), or regression to the mean cannot be excluded. No randomised controlled trial has proven that systemic stem cell infusion extends lifespan, improves healthspan, or reverses biological age markers in humans. Yet clinics market exactly these promises, sometimes to wealthy and credulous patients.
The "longevity" angle is where hype reaches peak intensity. A clinic might cite aging hallmarks (telomere shortening, epigenetic drift, mitochondrial dysfunction) and assert that stem cells reverse them. This is biological speculation dressed as established fact. Animal models show some senescence-reversing effects of stem cell treatment, but humans are far more complex. Ageing is multicausal and deeply programmed; a single stem cell infusion cannot undo it. Any clinic claiming stem cell therapy reverses ageing is operating well beyond evidence and should be regarded with scepticism.
One legitimate anti-ageing use exists: stem cell treatment for age-related joint or bone disease. Osteoarthritis is an age-related condition, and mesenchymal stem cell therapy for knee or hip arthritis is reasonable and well-evidenced relative to other anti-ageing interventions. Similarly, stem cell therapy for age-related erectile dysfunction or urinary incontinence has some published support. But these are condition-specific applications, not general anti-ageing. Before pursuing stem cell therapy for cosmetic or longevity reasons, ask: "Is there a published randomised controlled trial showing benefit for this condition?" If the answer is no, the treatment is experimental and claims about benefit are speculation. Choose wisely.
商业价格观察结果各异，大多数细胞疗法用途仍处于研究阶段。与独立的合格医生核实来源范围、监管状态和建议的护理。